EssilorLuxottica (OTCMKTS:ESLOY) Shares Gap Down – Should You Sell?

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $143.39, but opened at $137.81. EssilorLuxottica shares last traded at $138.67, with a volume of 115,067 shares changing hands.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ESLOY. Citigroup restated a “buy” rating on shares of EssilorLuxottica in a report on Thursday, December 11th. HSBC upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Wednesday, January 14th. Royal Bank Of Canada reiterated an “outperform” rating on shares of EssilorLuxottica in a research report on Tuesday, October 28th. The Goldman Sachs Group reissued a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Finally, Zacks Research downgraded shares of EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Two research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Buy”.

EssilorLuxottica Stock Performance

The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.67 and a current ratio of 0.97. The business’s 50 day simple moving average is $157.88 and its 200-day simple moving average is $163.57.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.